IL-17/Th17 pathway is activated in acne lesions

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kelhälä, Hanna Leena ^a   Palatsi, Riitta ^a   Fyhrquist, Nanna ^b   Lehtimäki, Sari ^b   Väyrynen, Juha P ^a   Kallioinen, Matti ^a   Kubin, Minna E ^a   Greco, Dario ^b   Tasanen, Kaisa ^a   Alenius, Harri ^b   Bertino, Beatrice ^c   Carlavan, Isabelle ^c   Mehul, Bruno ^c   Déret, Sophie ^c   Reiniche, Pascale ^c   Martel, Philippe ^c   Marty, Carine ^c   Blume Peytavi, Ulrike ^d   Voegel, Johannes J ^c   Lauerma, Antti ^e  

^a UNIVERSITY OF OULU   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c Department of Pathology University of Oulu Oulu University Hospital ^*  (France)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CHEMOKINE; RNA;

ACNE; ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SKIN BIOPSY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; YOUNG ADULT; ACNE VULGARIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ACNE VULGARIS; ADAPTIVE IMMUNITY; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CHEMOKINES; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-17; RNA; TH17 CELLS; TRANSCRIPTOME;

EID: 84919450505     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105238     Document Type: Article

References (56)

1. Knutson DD (1974) Ultrastructural observations in acne vulgaris: The normal sebaceous follicle and acne lesions. J Invest Dermatol 62: 288-307.
2. Guy R, Kealey T (1998) The effects of inflammatory cytokines on the isolated human sebaceous infundibulum. J Invest Dermatol 110: 410-415. (Pubitemid 28158659)
3. Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121: 20-27. (Pubitemid 36900450)
4. Layton AM, Morris C, Cunliffe WJ, Ingham E (1998) Immunohistochemical investigation of evolving inflammation in lesions of acne vulgaris. Exp Dermatol 7: 191-197. (Pubitemid 28419410)
5. Norris JF, Cunliffe WJ (1988) A histological and immunocytochemical study of early acne lesions. Br J Dermatol 118: 651-659.
6. Kim J, Ochoa MT, Krutzik SR, Takeuchi O, Uematsu S, et al. (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169: 1535-1541. (Pubitemid 34809200)
7. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, et al. (2005) A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria. Infect Immun 73: 4512-4521. (Pubitemid 41105605)
8. Jugeau S, Tenaud I, Knol AC, Jarrousse V, Quereux G, et al. (2005) Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol 153: 1105-1113. (Pubitemid 41779563)
9. Kim J (2005) Review of the innate immune response in acne. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211: 193-198.
10. Kollisch G, Kalali BN, Voelcker V (2005) Various members of the toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114: 531-541. (Pubitemid 40478147)
11. Nagy I, Pivarcsi A, Koreck A, Széll M, Urbán E, et al. (2005) Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Invest Dermatol 124: 931-938. (Pubitemid 40629093)
12. Oeff MK, Seltmann H, Hiroi N, Nastos A, Makrantonaki E, et al. (2006) Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology 213: 266. (Pubitemid 44567850)
13. Dispenza MC, Wolpert EB, Gilliland KL, Dai JP, Cong Z, et al. (2012) Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. J Invest Dermatol 132: 2198-2205.
14. Hernández-Santos N, Gaffen SL (2012) Th17 cells in immunity to Candida albicans. Cell Host Microbe 11: 425-435.
15. Kistowska M, Gehrke S, Jankovic D, Kerl K, Fettelschoss A, et al. (2014) IL-1β drives inflammatory responses to Propionibacterium acnes in vitro and in vivo. J Invest Dermatol 134: 677-685.
16. Qin M, Pirouz A, Kim MH, Krutzik SR, Garbán HJ, et al. (2014) Propionibacterium acnes induces IL-1b secretion via the NLRP3 inflammasome in human monocytes. J Invest Dermatol 134: 381-388.
17. Shaheen B, Gonzalez M (2011) A microbial aetiology of acne: what is the evidence? Br J Dermatol 165: 474-485.
18. Zouboulis CC, Jourdan E, Picardo M (2014) Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. J Eur Acad Dermatol Venereol 28: 527-532.
19. Thiboutot DM, Layton AM, Eady EA (2014) IL-17: a key player in the P. acnes inflammatory cascade? J Invest Dermatol 134: 307-310.
20. Agak GW, Qin M, Nobe J, Kim MH, Krutzik SR, et al. (2014) Propionibacterium acnes induces an interleukin-17 response in acne vulgaris that is regulated by vitamin A and vitamin D. J Invest Dermatol 134: 366-373.
21. Furusawa H, Suzuki Y, Miyazaki Y, Inase N, Eishi Y (2012) Th1 and Th17 immune responses to viable Propionibacterium acnes in patients with sarcoidosis. Respir Investig 50: 104-109.
22. Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, et al. (2009) Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 55: 47-52.
23. Chronnell CM, Ghali LR, Ali RS, Quinn AG, Holland DB, et al. (2001) Human beta defensin -1 and -2 expression in human pilosebaceous units: Up-regulation in acne vulgaris lesions. J Invest Dermatol 117: 1120-1125. (Pubitemid 34205907)
24. Ingham E, Eady EA, Goodwin CE, Cove JH, Cunliffe WJ (1992) Proinflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol 98: 895-901.
25. Kang S, Cho S, Chung JH, Hammerberg C, Fisher GJ, et al. (2005) Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol 166: 1691-1699. (Pubitemid 40734392)
26. Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM (2006) Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Invest Dermatol 126: 1071-1079.
27. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on bias and variance. Bioinformatics 19: 185-193. (Pubitemid 36181903)
28. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B (Methodological) 57: 289-300.
29. Lehtimäki S, Savinko T, Lahl K, Sparwasser T, Wolff H, et al. (2012) The temporal and spatial dynamics of Foxp3+ Treg cell-mediated suppression during contact hypersensitivity responses in a murine model. J Invest Dermatol 132: 2744-2751.
30. Väyrynen JP, Vornanen JO, Sajanti S, Böhm JP, Tuomisto A, et al. (2012) An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer. Virchows Arch 460: 455-465.
31. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210. (Pubitemid 34679544)
32. Fogel P, Young SS, Hawkins DM, Ledirac N (2007) Inferential, robust non-negative matrix factorization analysis of microarray data. Bioinformatics 23: 44-49. (Pubitemid 46017854)
33. Alestas T, Ganceviciene R, Fimmel S, Müller-Decker K, Zouboulis CC (2006) Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands. J Mol Med (Berl) 84: 75-87. (Pubitemid 43099526)
34. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, et al. (2009) New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol 18: 821-832.
35. Nagy I, Pivarcsi A, Kis K, Koreck A, Bodai L, et al. (2006) Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect 8: 2195-2205. (Pubitemid 44335873)
36. Begon E, Michel L, Flageul B, Beaudoin I, Jean-Louis F, et al. (2007) Expression, subcellular localization and cytokinic modulation of toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 17: 497-506. (Pubitemid 350207160)
37. Bangert C, Brunner PM, Stingl G (2011) Immune functions of the skin. Clin Dermatol 29: 360-376.
38. Mouser PE, Baker BS, Seaton ED, Chu AC (2003) Propionibacterium acnes-reactive T helper-1 cells in the skin of patients with acne vulgaris. J Invest Dermatol 121: 1226-1228. (Pubitemid 37431000)
39. Loser K, Beissert S (2012) Regulatory T cells: banned cells for decades. J Invest Dermatol 132: 864-871.
40. Maddur MS, Miossec P, Kaveri SV, Bayry J (2012) Th17 cells: Biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 181: 8-18.
41. Martin DA, Towne JE, Kricorian G, Klekotka P, Gudjonsson JE, et al. (2013) The emerging role of IL-17 in the pathogenesis of psoriasis: Preclinical and clinical findings. J Invest Dermatol 133: 17-26.
42. Sabat R, Wolk K (2011) Research in practice: IL-22 and IL-20: Significance for epithelial homeostasis and psoriasis pathogenesis. J Dtsch Dermatol Ges 9: 518-523.
43. Wolk K, Warszawska K, Hoeflich C, Witte E, Schneider-Burrus S, et al. (2011) Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol 186: 1228-1239.
44. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203: 2271-2279. (Pubitemid 44498362)
45. Ganceviciene R, Fimmel S, Glass E, Zouboulis CC (2006) Psoriasin and follicular hyperkeratinization in acne comedones. Dermatology 213: 270-272. (Pubitemid 44567852)
46. Lee DY, Yamasaki K, Rudsil J, Zouboulis CC, Park GT, et al. (2008) Sebocytes express functional cathelicidin antimicrobial peptides and can act to kill Propionibacterium acnes. J Invest Dermatol 128: 1863-1866. (Pubitemid 351847367)
47. Lumsden KR, Nelson AM, Dispenza MC, Gilliland KL, Cong Z, et al. (2011) Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne. Br J Dermatol 165: 302-310.
48. Nelson AM, Zhao W, Gilliland KL, Zaenglein AL, Liu W, et al. (2008) Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. J Clin Invest 118: 1468-1478. (Pubitemid 351500440)
49. Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, et al. (2011) Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol 131: 677-687.
50. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD (1998) Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 111: 645-649. (Pubitemid 28452327)
51. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-1350.
52. Krueger JG, Fretzin S, Suárez-Fariñas M, Haslett PA, Phipps KM, et al. (2012) IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol 130: 145-154. e9.
53. Lowes MA, Russell CB, Martin DA, Towne JE, Krueger JG (2013) The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses. Trends Immunol 34: 174-181.
54. Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, et al. (2010) Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One 5: e14108.
55. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, et al. (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111: 1013-1020. (Pubitemid 351213378)
56. Xiao S, Jin H, Korn T, Liu SM, Oukka M, et al. (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181: 2277-2284.